The German Institute for Quality and Efficiency in Health Care (IQWiG) has selected four topics for development of HTA reports in 2018-2019

17

Apr 2018

Annually, the Institute for Quality and Efficiency in Health Care (IQWiG), asks the citizens to propose the topics for the future health technology assessment (HTA) reports at the web-site of ThemenCheck Medizin service. The IQWiG collects these proposals and then determines up to five topics of current interest per year for the HTA development. There are two following phases of HTA selection:

  • Selection of 15 key topics by citizens and patient representatives
  • Discussion of the topics selected in the first phase between the IQWiG and the members of the extended advisory board from a scientific point of view with the following final decision

Recently, the IQWiG has chosen four out of 31 themes proposed from November of 2016 to the end of July of the year of 2017 for the development of HTA reports:

  • Testicular cancer: Does a regular screening test lead to better treatment results for men aged 16 or older? (HTA18-01)
  • Cervical spine syndrome: influence of treatment duration and frequency of physiotherapy on the success of treatment (HTA18-02)
  • Prostate Cancer: Does the use of fusion biopsy lead to better patient outcomes compared to standard diagnostic procedures? (HTA18-03)
  • Mild depressive episode: Do non-medical procedures such as light and vitamin therapy lead to better results? (HTA18-04)

The first HTA reports from the above selection will presumably be published at the web-site of ThemeCheck Medizin service at the beginning of 2019.

The next process of topics’ selection will start in August of 2018. The suggestion of the topic can be done here.

See full details in German here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more